Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

RNA Editing02:23

RNA Editing

9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
Neural Regulation01:37

Neural Regulation

39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
CRISPR01:59

CRISPR

51.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A diagnostic plasma omics-biomarker for Alzheimer's disease informed by microglial single-cell transcriptomics: A pilot study.

Alzheimer's & dementia (New York, N. Y.)·2026
Same author

<i>TOMM40</i> '523' genotype induces sex- and tissue- specific differences in cholesterol and triglyceride levels in an <i>APOE-TOMM40</i> humanized mouse model.

bioRxiv : the preprint server for biology·2026
Same author

A diagnostic plasma omics-biomarker for Alzheimer's disease informed by microglial single-cell transcriptomics: A pilot study.

bioRxiv : the preprint server for biology·2026
Same author

[Expression of Concern] ISL1 promotes cancer progression and inhibits cisplatin sensitivity in triple‑negative breast cancer cells.

International journal of molecular medicine·2026
Same author

Quadrupole-Driven Chiral Emission with Dipole-Quadrupole Interference Gating in an Achiral Nanocrescent.

Nano letters·2026
Same author

Cell-specific DNA methylation in human alpha and beta cells regulates gene expression in type 2 diabetes.

Nature metabolism·2026
Same journal

A DNA-guided prokaryotic argonaute enables programmable RNA cleavage for sequencing and quality control of <i>in vitro</i>-transcribed RNAs.

Molecular therapy. Nucleic acids·2026
Same journal

Enhanced γ-globin reactivation and sickle cell correction through a repressor-to-activator motif switch in the <i>HBG1/2</i> promoters.

Molecular therapy. Nucleic acids·2026
Same journal

Optimizing twin prime editing components for scalable genome editing and therapy in spinocerebellar ataxia type 3.

Molecular therapy. Nucleic acids·2026
Same journal

Enhancing protein expression in humans through codon optimization with transformer and contrastive learning.

Molecular therapy. Nucleic acids·2026
Same journal

Neonatal expression of human FMRP isoform corrects cortical deficits and improves behavior in a mouse model of fragile X syndrome.

Molecular therapy. Nucleic acids·2026
Same journal

Meta-analysis of adverse events in clinical studies with antisense oligonucleotide therapies.

Molecular therapy. Nucleic acids·2026
查看所有相关文章

相关实验视频

Updated: Jul 7, 2025

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

9.6K

神经元类型特定的表观基因组编辑来降低SNCA表达:在同核蛋白病变中对精准医学的影响

Zhiguo Sun1, Boris Kantor2, Ornit Chiba-Falek3,4

  • 1CLAIRIgene, LLC, Durham, NC 27701, USA.

Molecular therapy. Nucleic acids
|December 22, 2023
PubMed
概括
此摘要是机器生成的。

我们开发了一种新型基因疗法,针对SNCA过度表达在帕金森病 (PD) 和患有勒维体 (DLB) 的痴呆症. 这种表观基因组疗法显示出有望通过专门减少受影响神经元中的SNCA来治疗同核蛋白病变.

关键词:
DLB DLB 的意思是DLB 的意思MT:编辑RNA/DNA的方法警方 警方 警方 警方帕金森病是帕金森氏症的一种疾病.这是SNCA的SNCA.这是一种α-synuclein.胆固醇神经元是一种神经元.患有利维体痴呆症的痴呆症多巴胺类神经元的神经元编辑表观遗传学编辑基因治疗的基因疗法这是 hiPSC.人类诱导的多能干细胞干细胞.隐形病毒载体 隐形病毒载体合成核蛋白病变 (synucleinopathies) 是一种同核蛋白病变.

更多相关视频

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
07:49

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

956
Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
08:33

Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models

Published on: March 24, 2019

7.5K

相关实验视频

Last Updated: Jul 7, 2025

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

9.6K
CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
07:49

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

956
Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
08:33

Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models

Published on: March 24, 2019

7.5K

科学领域:

  • 神经科学是一个神经科学.
  • 遗传学 遗传学是一种遗传学.
  • 分子生物学分子生物学

背景情况:

  • 过度表达SNCA基因是像帕金森病 (PD) 和患有勒维体 (DLB) 的痴呆症等同核蛋白病变的核心.
  • 尽管有共同的相似之处,PD和DLB表现出明显的病理特征,需要有针对性的治疗方法.
  • 目前针对同核蛋白病变的治疗方法主要是治疗症状,这凸显了对疾病修饰疗法的需要.

研究的目的:

  • 设计一种针对神经元类型的特异性表观基因组疗法,针对SNCA针对同核蛋白病变.
  • 为了在涉及PD和DLB的多巴胺和胆固醇神经元中实现SNCA的精确下调.
  • 在人类诱导多能干细胞 (hiPSC) 衍生神经元模型中验证该系统的治疗潜力.

主要方法:

  • 使用CRISPR-dSaCas9和针对SNCA内核1的导向RNA (gRNA) 开发一个全集的隐形病毒载体系统.
  • 将CRISPR系统与KRAB/MeCp2转录抑制域 (TRD) 融合以实现基因沉默.
  • 利用神经元类型特定的促进剂 (TH用于多巴胺基神经元,ChAT用于胆固醇神经元) 来驱动治疗系统.

主要成果:

  • 在患有SNCA三倍化患者的hiPSC衍生神经元中,SNCA mRNA和蛋白质的有效和特定下调.
  • 拯救与疾病相关的细胞表型,包括减少Ser129-酸化α-synuclein,改善神经元活力和纠正线粒体功能障碍.
  • 在体外成功证明了一种新的神经元特异性SNCA向的表观基因组疗法.

结论:

  • 一种针对SNCA过度表达的新型神经元类型特异性表观基因组疗法已成功开发.
  • 该系统显示了治疗PD和DLB等同核蛋白病变的巨大潜力.
  • 这项研究为进一步的临床前开发和最终的临床试验提供了坚实的基础.